QR-Code

Chidamide-based 3-drug combination regimen reverses molecular relapse post transplantation in AML1-ETO–positive acute myeloid leukemia

Objective: We aimed to explore a new method to reverse early relapse in patients with AML1-ETO–positive acute myeloid cell transplantation.Methods: A chidamide-based 3-drug combination regimen was used in our center to treat patients with AML1-ETO–positive AML post transplantation but negative flow...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Yang Xi, Li Chenglong, Zhang Rong, Wang Wen, Wang Yu, Chen Jiao, Huang Juan, Che Feifei, Xiao Rong, Jiang Tao, Li Hui, Huang Xiaobing
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2023-01-01
Schriftenreihe:Frontiers in Pharmacology
Schlagworte:
chidamide
3-drug combination
AML1-ETO
post-transplantation
relapse
Online-Zugang:https://www.frontiersin.org/articles/10.3389/fphar.2022.1059930/full
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge